About PPA   |   Contact Us   |   Report Abuse   |   Sign In   |   Join Now
CE Webinar: Putting the Fire Out: Intranasal Naloxone and The Emerging Role of the Pharmacist
Tell a Friend About This EventTell a Friend
CE Webinar: Putting the Fire Out: Intranasal Naloxone and The Emerging Role of the Pharmacist

Join us for this convenient online CE webinar!

7/6/2016
When: Wednesday, July 6, 2016
1 to 2:30 PM
Where: Webinar
Access instructions provided upon registration
United States
Presenter: Karen Steinmetz Pater, PharmD, BCPS, CDE & Jennifer Pruskowski, PharmD, BCPS, CGP, CPE
Contact: Sara Powers
(717) 234-6151 x. 2


Online registration is closed.
« Go to Upcoming Event List  

Title: Putting the Fire Out: Intranasal Naloxone and The Emerging Role of the Pharmacist

Death from opioid overdoses is a growing epidemic in the United States, with deaths having more than tripled since 1999. Naloxone, a pure opioid antagonist, has been hypothesized as a possible agent to combat this epidemic. When administered intranasally, naloxone has been shown to be as effective as the intravenous route. This formulation, as well as the recent passing of PA Act 139, has also allowed for simple mass distribution across Pennsylvania. Despite these allowances, myths and controversies surrounding this agent, as well as the role of the pharmacist, exist. This continuing education session will describe the current opioid epidemic and the role of intranasal naloxone. It will also review the current literature base surrounding the use of intranasal naloxone and trends in opioid abuse, and finally describe the role of the pharmacist in dispensing intranasal naloxone.

 
Speakers:


Karen Steinmetz Pater, PharmD, BCPS, CDE, Assistant Professor, University of Pittsburgh School of Pharmacy, Department of Pharmacy and Therapeutics

Dr. Pater is an Assistant Professor at the University of Pittsburgh School of Pharmacy and an Outpatient Advanced Practice Pharmacist at the UPMC Matilda Theiss Health Center. She received her PharmD from the University of Tennessee Memphis College of Pharmacy, and completed a primary care residency at Shands Jacksonville. She is a Board Certified Pharmacotherapy Specialist and a Certified Diabetes Educator. She has spent the majority of her academic career educating students on outpatient pharmacy practice and self-care strategies. She has served as President of the Allegheny County Pharmacist Association and is the immediate Past Chair of the AACP Self-Care and Non-prescription Therapies Self-Care Sig.


Jennifer Pruskowski, PharmD, BCPS, CGP, CPE, Assistant Professor, University of Pittsburgh School of Pharmacy, Department of Pharmacy and Therapeutics

Dr. Pruskowski is an Assistant Professor at the University of Pittsburgh School of Pharmacy and the Palliative Care Clinical Pharmacists for the UPMC Palliative and Supportive Institute. She received her PharmD from Wilkes University, completed her PGY1 Pharmacy Practice and PGY2 Geriatric Pharmacy Residency at the William Jennings Bryan Dorn Veterans Affairs Medical Center in Columbia, South Carolina, and completed her Interprofessional Palliative Care Fellowship at James J. Peters Veterans Affairs Medical Center in Bronx, New York. She is a Board Certified Pharmacotherapy Specialist, Certified Geriatric Pharmacist, and Certified Pain Educator, and has received specialized training in pain and palliative care pharmacy through the American Society of Consultant Pharmacists and the American Society of Health-System Pharmacists.


   

Target Audience: All Pharmacists

  
CE Credit: 1.5 Contact Hours (0.15 CEUs)

Program Objectives:

At the completion of this activity, the participant will be able to
1. Describe the current opioid epidemic and the role of intranasal naloxone
2. Review the pharmacology of intranasal naloxone
3. Debate whether the utilization of intranasal naloxone will increase opioid misuse and abuse
4. Illustrate the role of the pharmacist in the dispensing of intranasal naloxone
  
Schedule: 12:55 to 1:00 PM - Attendees log in
1:00 to 2:30 PM - CE Program
Activity Type: Application-based
Cost: PPA Members - Free
Non-Members - $20
   *Requests for cancellation refunds must be submitted to PPA at least one day in advance of the webinar. All refunds will be subject to a $5 administrative fee.
UAN: 0159-0000-16-016-L01-P
Requirements to receive credit: Participants must attend the entire program and complete an online evaluation survey within one week. PPA must have your CPE Monitor ID and birthday on file to issue credit.

   

To Register:

Use the link above to register for this program. 


Click here to view current software requirements


The Pennsylvania Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Association Management Software Powered by YourMembership  ::  Legal